http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4626510-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24ee24573c48d111446592143ef1abe8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-75
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70
filingDate 1983-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1986-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa86ea7e400ad30c72325cdeae76cc8d
publicationDate 1986-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4626510-A
titleOfInvention Plasmidic vectors for expressing in bacillus subtilis and a method of preparing them
abstract A special description is given of plasmids pSM15, pSM16 and pSM17, which are hybrid plasmids derived by coupling pUB110 and modified pE194. The described plasmids are cloning vectors in Bacillus subtilis and are characterised by a marker of resistance to Kanamycin and an EcoRI site located near the end of the ribosome recognition sequence; they can also be used to induce the coded heterologous protein from cloned DNA with sub-inhibiting doses of erythromycin. n These plasmids are prepared via the formation of plasmids pSM4, pSM5 or pSM6, which can be expressed either in B. subtilis or in E. coli.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4987078-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008136790-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4806426-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4987069-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6017880-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5900400-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5334531-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6132990-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5585260-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4705750-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5871956-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6869925-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6291662-B1
priorityDate 1982-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4430434-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0063953-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12560
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395361
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226474347
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14710
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54685767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395099
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54675776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66577477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395008

Total number of triples: 45.